Cost–effectiveness of overactive bladder treatments from a US commercial and payer perspective

Aim: The cost–effectiveness of treatment options (anticholinergics, β3-adrenoceptor agonists, onabotulinumtoxinA, sacral nerve stimulation and percutaneous tibial stimulation [the latter two including new rechargeable neurostimulators]) for the management of overactive bladder (OAB) were compared...

Full description

Bibliographic Details
Main Authors: Brian Murray, Jennifer Miles-Thomas, Amy J Park, Victor B Nguyen, Amy Tung, Patrick Gillard, Anjana Lalla, Victor W Nitti, Christopher J Chermansky
Format: Article
Language:English
Published: Becaris Publishing Limited 2023-01-01
Series:Journal of Comparative Effectiveness Research
Subjects: